Keywords: آنتی ژن غشای خاص پروستات; Prostate cancer; Prostate-specific membrane antigen; Near-infrared fluorophore; Biomedical imaging; Glutamate-urea-lysine;
مقالات ISI آنتی ژن غشای خاص پروستات (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: آنتی ژن غشای خاص پروستات; Abscopal effect; mCRPC; Positron emission tomography; Prostate-specific membrane antigen; Radium-223;
Keywords: آنتی ژن غشای خاص پروستات; Prostate cancer; Prostate-specific membrane antigen; Positron emission tomography; Androgen pathway blockade;
Keywords: آنتی ژن غشای خاص پروستات; IGZO; Indium gallium ZnO; CMOS; Complementary metal-oxide semiconductor; PAC; Polymer-like amorphous carbon; AFP; Anti-α-feptoprotein; PSA; Prostate specific antigen; cTnT; Cardiac troponin T; CEA; Carcinoembryonic antigen; PNA; Peptide nucleic acid; APT
Keywords: آنتی ژن غشای خاص پروستات; Prostate cancer; Prostate-specific membrane antigen; PET; PSMA PET/CT; PSMA PET;
Keywords: آنتی ژن غشای خاص پروستات; Medullary thyroid cancer; Prostate-specific membrane antigen; Theranostics; Tissue microarray; Immunohistochemistry; Imaging;
Keywords: آنتی ژن غشای خاص پروستات; 56MESS; (1S2S-diaminocyclohexane)platinum(II)] dichloride; AIBN; 2,2â²-azobisisobutyronitrile; Apt; aptamer; AUC; area under curve; BBR3464; (trans,trans,trans)-bis-mu-(hexane-16-diamine)-mu-[diammineplatinum(II)]bis[diammine(chloro)platinum(II)] tetrani
Keywords: آنتی ژن غشای خاص پروستات; Ag@MSN; silver hybridized mesoporous silica nanoparticles; AFP; alpha-fetoprotein; APBA; 3-aminophenylboroic acid; APTES; 3-aminopropyltriethoxysilane; APTMS; aldehyde propyltrimethoxysilane; AuNPs@GMCs; graphitized mesoporous carbon-gold nanoparticles; B
Keywords: آنتی ژن غشای خاص پروستات; Phosphoramidate; Inhibitor; Prostate-specific membrane antigen; 4-Hydroxyproline; Prostate cancer;
Keywords: آنتی ژن غشای خاص پروستات; Prostate cancer; Prostate-specific membrane antigen; Folate; Cancer therapeutics; Tumor markers
Efficacy, Predictive Factors, and Prediction Nomograms for 68Ga-labeled Prostate-specific Membrane Antigen-ligand Positron-emission Tomography/Computed Tomography in Early Biochemical Recurrent Prostate Cancer After Radical Prostatectomy
Keywords: آنتی ژن غشای خاص پروستات; Biochemical recurrence; Prostate cancer; Prostate-specific membrane antigen; Positron-emission tomography/computed tomography; Prediction model;
Structure-activity relationships of succinimidyl-Cys-C(O)-Glu derivatives with different near-infrared fluorophores as optical imaging probes for prostate-specific membrane antigen
Keywords: آنتی ژن غشای خاص پروستات; Succinimidyl-cysteine-glutamate; Prostate-specific membrane antigen; Optical imaging; IRDye 800CW; IRDye 680; IRDye 750;
Comparison Between 64Cu-PSMA-617 PET/CT and 18F-Choline PET/CT Imaging in Early Diagnosis of Prostate Cancer Biochemical Recurrence
Keywords: آنتی ژن غشای خاص پروستات; Positron emission tomography/computed tomography; Prostate-specific membrane antigen; Radical prostatectomy; Restaging;
Antibody-drug conjugates (ADCs): Potent biopharmaceuticals to target solid and hematological cancers- an overview
Keywords: آنتی ژن غشای خاص پروستات; Antibody-drug conjugates; Monoclonal antibodies; Anticancer; Drug resistance; Solid tumors; Hematological tumors; ADC; Antibody-Drug Conjugate; ALCL; Anaplastic Large Cell Lymphoma; ALL; Acute Lymphoblastic Leukemia; AML; Acute Myeloid Leukemia; BCMA; B C
Uptake of Prostate-Specific Membrane Antigen (PSMA) in adenoid cystic carcinoma - Is PSMA-PET-CT a helpful tool in radiation oncology?
Keywords: آنتی ژن غشای خاص پروستات; ACC; Adenoid cystic carcinoma; CTCAE; Common terminology criteria of adverse events; IMRT; intensity modulated radiotherapy; HIT; Heidelberg Ion Beam Therapy Center; IHC; Immunohistochemistry; PET-CT; Positron emission tomography-computed tomography; PSMA
Synthesis and evaluation of a novel near-infrared fluorescent probe based on succinimidyl-Cys-C(O)-Glu that targets prostate-specific membrane antigen for optical imaging
Keywords: آنتی ژن غشای خاص پروستات; Prostate-specific membrane antigen; Optical imaging; IRDye 800CW; Succinimidyl-cysteine-glutamate;
A PSMA-targeted theranostic agent for photodynamic therapy
Keywords: آنتی ژن غشای خاص پروستات; Prostate-specific membrane antigen; Prostate cancer; PDT; Optical imaging; Molecular imaging;
Correlation of PSMA-Targeted 18F-DCFPyL PET/CT Findings With Immunohistochemical and Genomic Data in a Patient With Metastatic Neuroendocrine Prostate Cancer
Keywords: آنتی ژن غشای خاص پروستات; Immunohistochemistry (IHC); Metastatic prostate cancer; Neuroendocrine prostate cancer; Positron emission tomography/computed tomography (PET/CT) imaging; Prostate-specific membrane antigen;
Gallium-68 Prostate-Specific Membrane Antigen PET Imaging
Keywords: آنتی ژن غشای خاص پروستات; Prostate cancer; Prostate-specific membrane antigen; PET; 68Ga-PSMA; 68Ga-PSMA PET;
Initial Experience of 68Ga-PSMA PET/CT Imaging in High-risk Prostate Cancer Patients Prior to Radical Prostatectomy
Keywords: آنتی ژن غشای خاص پروستات; Prostate-specific membrane antigen; Positron-emission tomography; Prostate cancer; Lymph node metastasis; Imaging;
PSMA Theranostics Using PET and Subsequent Radioguided Surgery in Recurrent Prostate Cancer
Keywords: آنتی ژن غشای خاص پروستات; Biochemical recurrence; Molecular targeting; Positron emission tomography; Prostate-specific membrane antigen; Radiopharmaceuticals; Salvage surgery;
Development of 99mTc-labeled asymmetric urea derivatives that target prostate-specific membrane antigen for single-photon emission computed tomography imaging
Keywords: آنتی ژن غشای خاص پروستات; Prostate-specific membrane antigen; Single-photon emission computed tomography; Anionic 99mTc-tricarbonyl complex
Sensitivity, Specificity, and Predictors of Positive 68Ga-Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis
Keywords: آنتی ژن غشای خاص پروستات; Biochemical recurrence; Prostate cancer; Imaging; Positron emission tomography; Prostate-specific membrane antigen; Metastases; Sensitivity; Prostate-specific antigen;
PET/MRI:
Keywords: آنتی ژن غشای خاص پروستات; PET/MRI; PET/MR; Oncology; mMR; Whole-body imaging; AC; attenuation correction; CHO; [11C]choline; CMS; Centers for Medicare & Medicaid Services; CT; computed tomography; DWI; diffusion-weighted imaging; FACBC; anti-1-amino-3[18F]fluorocyclobutyl-1-carbox
Long non-coding RNA: A newly deciphered “code” in prostate cancer
Keywords: آنتی ژن غشای خاص پروستات; Androgen receptor; LNCaP; Biomarker; PCa; prostate cancer; ncRNA; non-coding RNAs; lncRNA; long ncRNA; miRNA; microRNA; snRNA; small nuclear RNA; siRNA; small interfering RNA; tRNA; transfer RNA; rRNA; ribosomal RNA; PCA3; PCa antigen 3; PIN; prostatic in
Radiolabeled enzyme inhibitors and binding agents targeting PSMA: Effective theranostic tools for imaging and therapy of prostate cancer
Keywords: آنتی ژن غشای خاص پروستات; Enzyme inhibitors; Gallium-68; Lutetium-177; Prostate cancer; Prostate-specific membrane antigen; Targeted radionuclide therapy
Prostate-specific Membrane Antigen-radioguided Surgery for Metastatic Lymph Nodes in Prostate Cancer
Keywords: آنتی ژن غشای خاص پروستات; Prostate-specific membrane antigen; Positron emission tomography; Radioguided; Prostate cancer;
Bioconjugates for targeted delivery of therapeutic oligonucleotides
Keywords: آنتی ژن غشای خاص پروستات; ASO; antisense oligonucleotide; CDM; carboxylated dimethyl maleic acid; CPP; cell penetrating peptide; DPC; dynamic polyconjugate; ED50; median effective dose; GalNAc; N-acetylgalactosamine; LNP; lipid nanoparticle; NP; nanoparticle; ON; oligonucleotide;
PET/Computed Tomography Using New Radiopharmaceuticals in Targeted Therapy
Keywords: آنتی ژن غشای خاص پروستات; PET/CT; Radiopharmaceutical; Targeted therapy; Somatostatin receptor; Prostate-specific membrane antigen; Hormone receptor; Tyrosine kinase; Angiogenesis;
Structural characterization of P1′-diversified urea-based inhibitors of glutamate carboxypeptidase II
Keywords: آنتی ژن غشای خاص پروستات; BBB, blood–brain barrier; GCPII, glutamate carboxypeptidase II; NAAG, N-acetyl-aspartyl-glutamate; QM, quantum mechanics; PCa, prostate cancer; SAR, structure-activity relationshipGCPII; Prostate-specific membrane antigen; PSMA; Metallopeptidase; X-ray cr
A heterodimeric [RGD-Glu-[64Cu-NO2A]-6-Ahx-RM2] αvβ3/GRPr-targeting antagonist radiotracer for PET imaging of prostate tumors
Keywords: آنتی ژن غشای خاص پروستات; Gastrin-releasing peptide; Prostate-specific membrane antigen; Bombesin; Prostate cancer; Copper-64;
Synthesis and biological evaluation of copper-64 radiolabeled [DUPA-6-Ahx-(NODAGA)-5-Ava-BBN(7-14)NH2], a novel bivalent targeting vector having affinity for two distinct biomarkers (GRPr/PSMA) of prostate cancer
Keywords: آنتی ژن غشای خاص پروستات; Gastrin-releasing peptide; Prostate-specific membrane antigen; Bombesin; Prostate cancer; Copper-64
Targeting prostate cancer cells with PSMA inhibitor-guided gold nanoparticles
Keywords: آنتی ژن غشای خاص پروستات; AuNPs; gold nanoparticles; GCPII; glutamate carboxypeptidase II; ICP-OES; inductively coupled plasma optical emission spectroscopy; PEG; polyethylene glycol; PSMA; prostate-specific membrane antigen; PSMAâ; PSMA-negative; PSMA+; PSMA-positive; TEM; tran
PSA-responsive and PSMA-mediated multifunctional liposomes for targeted therapy of prostate cancer
Keywords: آنتی ژن غشای خاص پروستات; Prostate cancer; Prostate-specific antigen; Prostate-specific membrane antigen; Tumor microenvironment stimulus-responsive liposomes; Cell-penetrating peptide; Small interfering RNA;
PSMA specific single chain antibody-mediated targeted knockdown of Notch1 inhibits human prostate cancer cell proliferation and tumor growth
Keywords: آنتی ژن غشای خاص پروستات; Single-chain antibody; Small interfering RNA; Prostate-specific membrane antigen; Notch1; Prostate cancer
Prostate-specific membrane antigen-based imaging
Keywords: آنتی ژن غشای خاص پروستات; Prostate-specific membrane antigen; Prostate cancer; Molecular imaging; Monoclonal antibody; Single-photon emission computed tomography; Positron emission tomography
Combination of the PI3K Inhibitor ZSTK474 with a PSMA-Targeted Immunotoxin Accelerates Apoptosis and Regression of Prostate Cancer
Keywords: آنتی ژن غشای خاص پروستات; J591PE; a protein chimera between the single-chain variable fragment of the monoclonal antibody J591 against the prostate-specific membrane antigen and the truncated form of the Pseudomonas aeruginosa exotoxin A (PE38QQR); PSMA; prostate-specific membrane
Glycosylation of prostate specific antigen and its potential diagnostic applications
Keywords: آنتی ژن غشای خاص پروستات; 2-DE; two-dimensional electrophoresis; AA(A); Aleuria aurantia agglutinin; AMACR; α-methylacyl-CoA racemase; BPH; benign prostatic hyperplasia; BPSA; benign prostatic hyperplasia associated PSA; Con A; Concanavalin A; CE; capillary electrophoresis; ELLA;
Ten-Year Outcomes: The Clinical Utility of Single Photon Emission Computed Tomography/Computed Tomography Capromab Pendetide (Prostascint) in a Cohort Diagnosed With Localized Prostate Cancer
Keywords: آنتی ژن غشای خاص پروستات; Capromab pendetide; Prostascint; Prostate-specific membrane antigen; Staging; Image-guided radiotherapy;
Prostate-specific membrane antigen-targeted photodynamic therapy induces rapid cytoskeletal disruption
Keywords: آنتی ژن غشای خاص پروستات; Cytoskeleton; Prostate-specific membrane antigen; Photodynamic therapy; Pyropheophorbide-a; Apoptosis
IRX-2 increases the T cell-specific immune response to protein/peptide vaccines
Keywords: آنتی ژن غشای خاص پروستات; IRX-2; Adjuvants; Prostate-specific membrane antigen; Aging; Cytokines; Vaccine
A low molecular weight PSMA-based fluorescent imaging agent for cancer
Keywords: آنتی ژن غشای خاص پروستات; Prostate-specific membrane antigen; NAALADase; Fluorescence; Urea; Molecular imaging
Binding of prostate-specific membrane antigen to dendritic cells: a critical step in vaccine preparation
Keywords: آنتی ژن غشای خاص پروستات; Antigenic peptides; dendritic cells; prostate cancer; prostate-specific membrane antigen; vaccines
Phosphoramidate derivatives of hydroxysteroids as inhibitors of prostate-specific membrane antigen
Keywords: آنتی ژن غشای خاص پروستات; PSMA; Prostate-specific membrane antigen; Glutamate carboxypeptidase II; Steroid; Molecular docking; Phosphoramidate
Multidimensional approaches in dealing with prostate cancer
Keywords: آنتی ژن غشای خاص پروستات; AR; androgen receptor; ARE; androgen response element; CaP; carcinoma of prostate; CBP; Creb-Binding Protein; CPA; cyproterone acetate; CT; computed tomography; EDT; estrogen deprivation therapy; ER; estrogen receptor; GM-CSF; granulocyte macrophage colon
Substrate specificity of prostate-specific membrane antigen
Keywords: آنتی ژن غشای خاص پروستات; Prostate-specific membrane antigen; PSMA; Glutamate carboxypeptidase II; Substrate specificity; Molecular docking
Promoter analysis of human glutamate carboxypeptidase II
Keywords: آنتی ژن غشای خاص پروستات; Glutamate carboxypeptidase II; Prostate-specific membrane antigen; Regulation of gene transcription; Promoter; Lymphoid transcription factor 1 (LyF-1); Schizophrenia;
Association of prostate-specific membrane antigen with caveolin-1 and its caveolae-dependent internalization in microvascular endothelial cells: Implications for targeting to tumor vasculature
Keywords: آنتی ژن غشای خاص پروستات; Prostate cancer; Prostate-specific membrane antigen; Human microvascular endothelial cells; Neovasculature; Endocytosis; Caveolae
Optimizing phenylethylphosphonamidates for the inhibition of prostate-specific membrane antigen
Keywords: آنتی ژن غشای خاص پروستات; Prostate-specific membrane antigen; PSMA; Glutamate carboxypeptidase II; Phosphonamidate; Topliss
New approaches to identification of antigenic candidates for future prostate cancer immunotherapy
Keywords: آنتی ژن غشای خاص پروستات; AMACR; α-methylacyl-CoA racemase; cDNA; complementary deoxyribonucleic acid; CTA; cancer-testis antigen(s); CTL; cytolytic T lymphocyte; ELISPOT; enzyme-linked immunosorbent spot assay; EpCAM; epithelial cell adhesion molecule; HLA; human leukocyte antig